Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery]Shinichiro Kashiwagi, Sae Ishihara, Mariko Ishii, et al.Journal of Clinical Gastroenterology|October 24, 2012
The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablationHiroki Nishikawa, Yukio Osaki, Eriko Iguchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Effectiveness of eribulin chemotherapy for squamous cell carcinoma of the breast]Shinichiro Kashiwagi, Tomohisa Okuno, Sae Ishihara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Two cases of the primary small intestine cancer successfully treated with S-1 and UFT/LV therapy]Tomohiro Lee, Eiji Noda, Kiyoshi Maeda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Docetaxel with concurrent radiotherapy in patients with inoperable or relapsed oesophageal cancer]Naoshi Kubo, Jyunya Morimoto, Katsunobu Sakurai, et al.Molecular and Clinical Oncology|April 18, 2017
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancerKenji Tezuka, Tsutomu Takashima, Shinichiro Kashiwagi, et al.Springerplus|March 31, 2016
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancerTsutomu Takashima, Shinya Tokunaga, Seika Tei, et al.Anticancer Research|April 7, 2019
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II TrialShinya Tokunaga, Tsutomu Takashima, Shinichiro Kashiwagi, et al.Anticancer Research|October 1, 2021
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast CancerTsutomu Takashima, Shigehiko Nishimura, Hidemi Kawajiri, et al.Anticancer Research|December 27, 2017
Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast CancerTsutomu Takashima, Hidemi Kawajiri, Takeo Nishimori, et al.Pageof 11